Health Trials

Invasive Home Ventilation in Denmark

ConditionsNeuromuscular Diseases (NMD)ALS (Amyotrophic Lateral Sclerosis)Spinal Cord Injuries (SCI)Duchenne Muscular Dystrophy (DMD)SMA - Spinal Muscular AtrophyMSA - Multiple System AtrophyTracheostomized PatientsTracheostomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorRigshospitalet, Denmark

About this trial

The aim of this study is to describe national trends over the past 10 years in patients receiving invasive home mechanical ventilation (HMV) in Denmark. This includes indications for invasive HMV, diagnostic groups, and one-year mortality.

Eligibility criteria

Qualifiers

Patients are included if they have or have had a respiratory certified personale care assistent during the period 2016-2025.

Disqualifiers

Not tracheostomized

Tracheostomized but on spontaneous breathing throughout 1 January 2016 - 31 December 2025

Not discharged to home, assisted living, nursing home, or rehabilitation during 1 January 2016 - 31 December 2025

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

450 Participants
are grouped into 1 trial group

Sponsors and collaborators

Rigshospitalet, Denmark

Lead sponsor

Aarhus University Hospital

Collaborator

Odense University Hospital

Collaborator

Source ClinicalTrials.gov